Medicare’s experiment to fix kidney failure to end early
The Centers for Medicare and Medicaid Services recently made the decision to end the End-Stage Renal Disease Treatment Choices (ETC) model, a groundbreaking experiment aimed at revolutionizing dialysis care in the United States. Led by Mehmet Oz, the agency announced that the trial will conclude on December 31, marking the end of a significant initiative in American healthcare.
The ETC model, a project of the CMS Innovation Center, was designed to assess whether offering financial incentives to healthcare providers could increase the number of end-stage kidney disease patients opting for home dialysis and pursuing transplantation. With the participation of 30% of the nation’s dialysis providers, this experiment was the largest of its kind in the history of healthcare in the U.S.
Despite high hopes for the program, the results have been disappointing. Analysis conducted after the first year of implementation in 2021 revealed that there was no significant impact on the rates of home dialysis or transplantation among patients. This trend continued in subsequent studies, with researchers noting that providers enrolled in the new payment model were not achieving higher rates of home dialysis or transplantations compared to their counterparts in the control group.
The decision to terminate the ETC model reflects the challenges and complexities of implementing large-scale healthcare reforms. While the goal of increasing access to home dialysis and transplantation remains crucial, it is evident that the current approach has not yielded the desired outcomes.
As we reflect on the conclusion of the ETC model, it is essential to consider alternative strategies for improving care for patients with end-stage renal disease. By learning from the experiences and insights gained through this experiment, healthcare providers and policymakers can work towards developing more effective interventions that address the needs of this vulnerable patient population. The journey towards transforming dialysis care in the U.S. continues, and the lessons learned from the ETC model will undoubtedly inform future efforts to enhance the quality of life for individuals with kidney disease.
